Renal Pelvis Cancer

• CLINICAL_TRIALS research · 2026-04-15
  Clinical Trial Update: ARID1A and/or KDM6A Mutation and CXCL13 Expression [Phase 2]

  Phase 2 clinical trial update from MD Anderson investigating ARID1A and/or KDM6A mutation status and CXCL13 expression in urothelial cancers…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy [Phase 1]

  A Phase 1 clinical trial is investigating the combination of Erdafitinib and Enfortumab Vedotin for metastatic bladder/urothelial cancers af…

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer [Phase 3]

  Phase 3 trial evaluating adding tivozanib to pembrolizumab after surgery for kidney cancer; currently recruiting.

• CLINICAL_TRIALS research · 2026-03-05
  Clinical Trial Update: Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery [EARLY_Phase 1]

  This early-phase trial update describes the combination of durvalumab and tremelimumab in cisplatin-ineligible muscle-invasive urothelial ca…

• CLINICAL_TRIALS research · 2025-08-22
  Clinical Trial Update: ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  Guardant Health's ORACLE trial is currently recruiting to evaluate residual cancer using a liquid biopsy across multiple cancer types.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2024-06-20
  Clinical Trial Update: Urine DNA Methylation Detection for Hematuria Evaluation

  ClinicalTrials.gov entry for a study evaluating urine DNA methylation as a noninvasive test to evaluate hematuria and screen for urothelial …